Your session is about to expire
← Back to Search
Telehealth vs In-Person Palliative Care for Lung Cancer (REACH PC Trial)
N/A
Waitlist Available
Led By Jennifer Temel, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed >50% of the day)
Age > or = 18 years
Must not have
Already receiving outpatient PC or hospice services
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing different ways to give palliative care to people with newly diagnosed lung cancer and their families.
Who is the study for?
This trial is for adults over 18 with advanced non-small cell lung cancer, treated without the aim of cure and informed about their condition within the last 12 weeks. They must be able to communicate in English or Spanish, live where the care team is licensed, and have a close contact involved. Excluded are those already in outpatient palliative care or hospice, or with cognitive/psychiatric conditions affecting consent.
What is being tested?
The study compares two ways of delivering palliative care: through telehealth services versus traditional in-person visits. It aims to determine which method better supports patients recently diagnosed with lung cancer and their families.
What are the potential side effects?
Since this trial involves methods of care delivery rather than medication, there aren't typical drug side effects. However, participants may experience differences in satisfaction, convenience, emotional well-being based on whether they receive telehealth or in-person palliative care.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can take care of myself but may spend more than half the day in bed due to my condition.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently getting palliative care or hospice services as an outpatient.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Caregiver satisfaction as measured by the Satisfaction with Care Delivery Questionnaire
Length of stay in hospice as collected per medical record review
Patient communication about end-of-life (EOL) care preferences as measured by patient self-report of communication about their wishes if they were dying
+2 moreOther study objectives
Anxiety
Caregiver prognostic understanding as measured by the Prognosis and Treatment Perception Questionnaire (PTPQ)
Caregiver quality of life (QOL) as measured by the Caregiver Oncology QOL Questionnaire
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TelehealthExperimental Treatment1 Intervention
* Patients will meet with the PC clinician in person within four weeks of enrollment
* Subsequent visits with the PC clinician will be conducted with the patients in their home or other location using video at least every four weeks
* Patients may be scheduled to meet with the PC clinician in the clinic if requested by the patient or a clinician
Group II: In Person PCActive Control1 Intervention
* Patients will be scheduled for their first In-person PC visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic
* PC visits will be scheduled on the same day as an oncology visit if possible
Find a Location
Who is running the clinical trial?
Palliative Care Research Cooperative GroupNETWORK
8 Previous Clinical Trials
911 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,412,549 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
580 Previous Clinical Trials
27,104,009 Total Patients Enrolled
Jennifer Temel, MDPrincipal Investigator - Massachusetts General Hospital
Massachusetts General Hospital, Massachusetts General Physicians Organization Inc
Washington University School Of Medicine (Medical School)
Brigham & Women'S Hospital (Residency)
11 Previous Clinical Trials
4,171 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can take care of myself but may spend more than half the day in bed due to my condition.You have mental health conditions that make it difficult for you to understand and participate in the study.I am 18 years old or older.I am currently getting palliative care or hospice services as an outpatient.I can read and answer questions in English or Spanish.I was told I have advanced lung cancer that can't be cured within the last 12 weeks.I have a relative or friend who sees me at least twice a week.
Research Study Groups:
This trial has the following groups:- Group 1: Telehealth
- Group 2: In Person PC
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.